PerkinElmer and Emerald Scientific Collaborate for Cannabis and Hemp Analytical Solutions and Services
PerkinElmer, Inc., announced a collaboration with Emerald Scientific, in which Emerald Scientific will offer PerkinElmer’s cannabis and hemp testing portfolio and services to its North American customers.
According to the company press release (1), Emerald Scientific customers will now be able to take advantage of PerkinElmer’s high throughput, advanced instruments and regulatory compliant software for cannabis and hemp testing including:
- A liquid chromatography–mass spectrometry (LC–MS) system for rapid identification and quantitation of pesticides, mycotoxins, and emerging residue contaminants
- A microwave sample preparation system for sample digestion for heavy metal analysis of cannabis flower, concentrates, and edibles
- A gas chromatography–MS (GC–MS) system, offering sensitivity and stability for identification and quantitation of volatile and semivolatile compounds such as residual solvents and terpenes
- A high performance liquid chromatography (HPLC) system to quantitate all major and minor cannabinoids in a cannabis or hemp matrix
The collaboration also reportedly enables both Emerald Scientific and PerkinElmer customers to utilize PerkinElmer’s analytical methods and standard operating procedures (SOPs) for cannabis and hemp analysis, which outline best practice sample preparation, acquisition methods, and consumable use. In addition, PerkinElmer’s services will be offered as well as their consumables such as chromatography columns, vials, and sample prep products.
“With the cannabis and hemp markets continuing to grow rapidly and regulations strengthening, labs increasingly need streamlined access to best-in-class, user-friendly testing solutions geared toward the unique requirements of the industry,” said Greg Sears, vice president and general manager, Food and Organic Mass Spectrometry, PerkinElmer. “This collaboration with Emerald Scientific brings together leading cannabis analysis offerings in one place to help labs start up and expand more efficiently. In addition, we can build on the work we have done with Emerald around testing standardization which is important for the science of the industry.”
“We are very excited about this collaboration with PerkinElmer,” said Kirsten Blake, Vice President, Emerald Scientific. “As regulations become more challenging, laboratory competition intensifies, and the science of the industry receives increasing focus, it is essential to align with organizations dedicated to improving both the quality and throughput of analytics. After working with PerkinElmer to inform, educate, and advance the cannabis science industry around best practices, we see them as the industry leader for providing analytical instrumentation, methods and SOP’s. By adding their complementary solutions to our existing portfolio, we can now deliver complete packaged analytical solutions to the cannabis and hemp industries.”
Reference
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
